Page last updated: 2024-08-17

dimethyl sulfone and ag-490

dimethyl sulfone has been researched along with ag-490 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, BW; Choi, YH; Darvin, P; Joung, YH; Kang, DY; Kim, HS; Kim, SY; Lee, HK; Na, YM; Park, JH; Park, KD; Sp, N; Yang, YM; Yoo, YB	1

Other Studies

1 other study(ies) available for dimethyl sulfone and ag-490

Article	Year
Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2/STAT3 pathway. International journal of oncology, 2014, Volume: 44, Issue:3 Topics: Animals; Cell Movement; Cell Survival; Dimethyl Sulfoxide; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Mice; Receptor, IGF Type 1; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; STAT5 Transcription Factor; Sulfones; Tyrphostins; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2014

Article

Year

Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2/STAT3 pathway.

International journal of oncology, 2014, Volume: 44, Issue:3

Topics: Animals; Cell Movement; Cell Survival; Dimethyl Sulfoxide; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Mice; Receptor, IGF Type 1; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; STAT5 Transcription Factor; Sulfones; Tyrphostins; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2014